The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate.
Chang
Kwok Chiu
KC
Leung
Chi Chiu
CC
D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects; D011718:Pyrazinamide / Q000008:administration & dosage / Q000009:adverse effects; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin